30S ribosomal subunit aminoacyl-tRNA site (30S A-site) (30S A-site)

The 30S ribosomal subunit aminoacyl-tRNA site (A-site) is a fundamental component of the bacterial translation machinery, primarily located within the 16S ribosomal RNA (rRNA) [PMID: 11054804]. Its primary biological function is the decoding of mRNA, where it ensures the high-fidelity selection of aminoacyl-tRNA molecules based on codon-anticodon complementarity [StatPearls: Biochemistry, Ribosome]. During translation, the A-site ensures high fidelity in protein synthesis by discriminating against non-cognate tRNAs [Nature: 10.1038/35030019]. In the context of infectious diseases, the A-site serves as a primary target for various classes of bactericidal and bacteriostatic antibiotics, including aminoglycosides and tetracyclines [PubMed: 25147135]. Aminoglycosides bind specifically to the internal loop of helix 44 in the 16S rRNA, inducing a conformational change that mimics the state of correct codon recognition, which leads to the incorporation of incorrect amino acids and subsequent cell death [NCBI: Bookshelf NBK541077]. While highly effective against Gram-negative and some Gram-positive bacteria, drugs targeting this site are associated with significant safety concerns, such as nephrotoxicity and ototoxicity, often due to structural similarities between bacterial and human mitochondrial ribosomes [NIH: LiverTox]. This target is central to the treatment of severe Gram-negative infections, though its utility is increasingly challenged by the emergence of resistance mechanisms such as rRNA methylation [NCBI: PMC3538121].

Other names

30S A-siteRibosomal decoding center16S rRNA A-siteAminoacyl-tRNA binding siteBacterial decoding site

Antibiotics targeting the 30S A-site interfere with the decoding process of translation. Aminoglycosides bind to the 16S rRNA, inducing a conformational change in residues A1492 and A1493, which forces them into an "out" configuration that mimics the presence of a correct codon-anticodon match; this leads to the incorporation of incorrect amino acids (mistranslation) [PMID: 11054804]. Tetracyclines, conversely, bind to the A-site and physically block the docking of aminoacyl-tRNA, thereby preventing the addition of new amino acids to the peptide chain and acting as bacteriostatic agents [NCBI: Bookshelf NBK541077].